Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Presley

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
Journal of the American Geriatrics Society|October 6, 2021
Changes in older adults' life space during lung cancer treatment: A mixed methods cohort studyMelisa L Wong, Ying Shi, Alexander K Smith, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 2023
Cancer-related Fatigue in Lung Cancer: A Research Agenda: An Official American Thoracic Society Research StatementBrett C Bade, Saadia A Faiz, Duc M Ha, et al.
Clinical Lung Cancer|July 27, 2025
Brief Report: Central Nervous System Metastases After Chemoradiation Followed by Durvalumab for Unresectable Locally Advanced Nonsmall Cell Lung CancerJohn Sharp, Philip Young, Songzhu Zhao, et al.
Journal of Geriatric Oncology|August 22, 2024
Resiliency among older adults receiving lung cancer treatment (ROAR-LCT): A novel supportive care intervention for older adults with advanced lung cancerCarolyn J Presley, Madison Grogan, Amy Compston, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2023
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapyMingjia Li, Songzhu Zhao, Gabrielle Lopez, et al.
Science Advances|April 20, 2018
Reconciling biodiversity and carbon stock conservation in an Afrotropical forest landscapeFrederik Van de Perre, Michael R Willig, Steven J Presley, et al.
Investigational New Drugs|December 3, 2025
Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancerDwight H Owen, Ruohan Wu, Lai Wei, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2023
Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung CancerAlexander Wong, Maria Riley, Songzhu Zhao, et al.
Journal of Cancer|June 22, 2026
Association between obesity, sex, medical comorbidities, and survival in cancer patients treated with immune checkpoint inhibitorsMingjia Li, Daniel J Spakowicz, Songzhu Zhao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2021
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint InhibitorsAngel Qin, Songzhu Zhao, Abdul Miah, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Journal of the American Geriatrics Society|October 6, 2021
Changes in older adults' life space during lung cancer treatment: A mixed methods cohort studyMelisa L Wong, Ying Shi, Alexander K Smith, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 2023
Cancer-related Fatigue in Lung Cancer: A Research Agenda: An Official American Thoracic Society Research StatementBrett C Bade, Saadia A Faiz, Duc M Ha, et al.
Clinical Lung Cancer|July 27, 2025
Brief Report: Central Nervous System Metastases After Chemoradiation Followed by Durvalumab for Unresectable Locally Advanced Nonsmall Cell Lung CancerJohn Sharp, Philip Young, Songzhu Zhao, et al.
Journal of Geriatric Oncology|August 22, 2024
Resiliency among older adults receiving lung cancer treatment (ROAR-LCT): A novel supportive care intervention for older adults with advanced lung cancerCarolyn J Presley, Madison Grogan, Amy Compston, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2023
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapyMingjia Li, Songzhu Zhao, Gabrielle Lopez, et al.
Science Advances|April 20, 2018
Reconciling biodiversity and carbon stock conservation in an Afrotropical forest landscapeFrederik Van de Perre, Michael R Willig, Steven J Presley, et al.
Investigational New Drugs|December 3, 2025
Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancerDwight H Owen, Ruohan Wu, Lai Wei, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2023
Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung CancerAlexander Wong, Maria Riley, Songzhu Zhao, et al.
Journal of Cancer|June 22, 2026
Association between obesity, sex, medical comorbidities, and survival in cancer patients treated with immune checkpoint inhibitorsMingjia Li, Daniel J Spakowicz, Songzhu Zhao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2021
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint InhibitorsAngel Qin, Songzhu Zhao, Abdul Miah, et al.
Pageof 19